Patents Examined by Ramin Akhavan
-
Patent number: 7067643Abstract: The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Enzymes, including 5? nucleases and 3? exonucleases, are used to detect and identify nucleic acids derived from microorganisms. Methods are provided which allow for the detection and identification of bacterial and viral pathogens in a sample.Type: GrantFiled: August 28, 2001Date of Patent: June 27, 2006Assignee: Third Wave Technologies, Inc.Inventors: James E. Dahlberg, Mary Ann D. Brow, Victor I. Lyamichev
-
Patent number: 7018833Abstract: The present invention relates to linear expression elements (LEEs) and circular expression elements (CEEs), which are useful in a variety of molecular biology protocols. Specifically, the invention relates to the use of LEEs and CEEs to screen for gene function, biological effects of gene function, antigens, and promoter function. The invention also provides methods of producing proteins, antibodies, antigens, and vaccines. Also, the invention relates to methods of making LEEs and CEEs, and LEEs and CEEs produced by such methods.Type: GrantFiled: February 15, 2002Date of Patent: March 28, 2006Assignee: Board of Regents, The University of Texas SystemInventors: Kathryn F. Sykes, Stephen Albert Johnston
-
Patent number: 7001768Abstract: Methods and compositions for targeted modification of chromatin structure, within a region of interest in cellular chromatin, are provided. Such methods and compositions are useful for facilitating processes such as, for example, transcription and recombination, that require access of exogenous molecules to chromosomal DNA sequences.Type: GrantFiled: April 27, 2001Date of Patent: February 21, 2006Assignee: Sangamo Biosciences, Inc.Inventor: Alan P. Wolffe
-
Patent number: 6949379Abstract: This invention provides methods of regulating gene expression. An aptamer is positioned in a nucleic acid molecule along with a sequence encoding a transcriptional regulatory polypeptide. The aptamer disrupts translation of the transcriptional regulatory polypeptide when contacted with an aptamer-binding ligand. Gene expression levels can be either increased or decreased by the disclosed methods, depending on whether the transcriptional regulatory polypeptide is a repressor or activator, and the degree of the effect is dependent upon the dose of the ligand. Nucleic acid molecules, expression cassettes, expression vectors and cells useful in the gene regulation methods are also provided.Type: GrantFiled: October 19, 2001Date of Patent: September 27, 2005Assignee: Canji, Inc.Inventor: Murali Ramachandra
-
Patent number: 6929917Abstract: The invention concerns a new method of detecting a rare product of a directed genetic alteration of a cultured cell. The method is applicable to any method of making the alteration provided that a pair of closely linked alterations can be made. The method consists of sequentially using allele specific polymerase chain reaction (PCR) to preferentially amplify sequences containing one of the two linked alterations coupled with a second method that detects the second change in the PCR product. The second method can be restriction digestion, traditional sequencing or pyro-sequencing. Experiments indicate that alterations as rare as one correctly altered copy in 10,000 cells can be detected.Type: GrantFiled: November 18, 2002Date of Patent: August 16, 2005Assignee: PreGentisInventors: Richard Metz, Mike DiCola, R. Michael Blaese
-
Patent number: 6916919Abstract: The present invention relates to a process for separating nucleic acid molecules, preferably open circular and supercoiled plasmid DNA and RNA molecules from each other, comprising the steps of providing a solution comprising the molecules; adsorbing the molecules to adsorbing groups on a carrier; and optionally washing the column with a suitable solution. The present process is especially suitable for large-scale isolation of supercoiled ccc DNA to be used in gene therapy.Type: GrantFiled: April 15, 2002Date of Patent: July 12, 2005Assignee: Amersham Biosciences ABInventors: Raf Lemmens, Tomas Nyhammar, Jan Berglof, Joachim Stadler
-
Patent number: 6913878Abstract: A method of detecting increased levels of DNA single strand breaks in a eukaryotic cell sample, comprising the steps of: (a) contacting a eukaryotic cell sample to a water-soluble tetrazolium salt under conditions in which said tetrazolium salt is converted to a formazan dye in said cell sample in the presence of NADH or NADPH; and then (b) detecting the presence of the formazan dye in said cell sample, with decreased levels of the formazan dye indicating increased levels of DNA single strand breaks in the eukaryotic cell sample.Type: GrantFiled: January 6, 2003Date of Patent: July 5, 2005Assignee: The University of North Carolina at Chapel HillInventors: Jun Nakamura, James A. Swenberg
-
Patent number: 6900018Abstract: The present invention relates to linear expression elements (LEEs) and circular expression elements (CEEs), which are useful in a variety of molecular biology protocols. Specifically, the invention relates to the use of LEEs and CEEs to screen for gene function, biological effects of gene function, antigens, and promoter function. The invention also provides methods of producing proteins, antibodies, antigens, and vaccines. Also, the invention relates to methods of making LEEs and CEEs, and LEEs and CEEs produced by such methods.Type: GrantFiled: February 15, 2002Date of Patent: May 31, 2005Assignee: Board of Regents, The University of Texas SystemInventors: Kathryn F. Sykes, Stephen Albert Johnston
-
Patent number: 6897040Abstract: The invention provides improved methods of recombinant protein production in cell culture. More specifically, the invention relates to the modulation of the IGF-1 signaling pathway in cells so as to improve production characteristics.Type: GrantFiled: March 29, 2002Date of Patent: May 24, 2005Assignee: Immunex CorporationInventors: Arvia E. Morris, Pranhitha Reddy
-
Patent number: 6855545Abstract: Methods and vectors (both DNA and retroviral) are provided for the construction of a Library of mutated cells. The Library will preferably contain mutations in essentially all genes present in the gene of the cells. The nature of the Library and the vectors allow for methods of screening for mutations in specific genes, and for gathering nucleotide sequence data from each mutated gene to provide a database of tagged gene sequences. Such a database provides a means to access the individual mutant cell clones contained in the Library. The invention includes the described Library, methods of making the same, and vectors used to construct the Library. Methods are also provided for accessing individual parts of the Library either by sequence or by pooling and screening. The invention also provides for the generation of non-human transgenic animals which are mutant for specific genes as isolated and generated from the cells of the Library.Type: GrantFiled: August 15, 2000Date of Patent: February 15, 2005Assignee: Lexicon Genetics Inc.Inventors: Arthur T. Sands, Glenn A. Friedrich, Brian Zambrowicz, Allan Bradley
-
Patent number: 6852511Abstract: The invention relates to nucleic acid molecules comprising a heat-inducible promoter and to expression vectors and host cells containing at least one nucleic acid molecule according to the invention. The present invention further relates to kits and methods for producing one or more proteins using the nucleic acid molecules according to the invention and to various uses of the same. The object of the invention is to provide a promoter the heat-inducible characteristic of which is as selective as possible, in particular a promoter which is active in yeasts and which is suitable for protein expression at high temperatures.Type: GrantFiled: August 9, 2001Date of Patent: February 8, 2005Assignee: Rhein Biotech, Gesellschaft für Neue Biotechnologische Prozesse und Produkte GmbHInventors: Ivano Romano, Gerd Gellissen, Claudio DeVirgilio
-
Patent number: 6852709Abstract: The present invention provides biodegradable polymers, polymer compositions, particles composed thereof and methods of using same for the controlled release of a biologically active substance to a specified tissue or cells. Preferred polymers include biodegradable, amphiphilic polyphosphates which are capable of complexing one or more biologically active substances. Preferred methods include the controlled release of biologically active substances and gene therapy using polymers and nanoparticles composed thereof.Type: GrantFiled: May 31, 2001Date of Patent: February 8, 2005Assignee: Johns Hopkins UniversityInventors: Kam Leong, Wen Jie, Hai-Quan Mao
-
Patent number: 6800458Abstract: A novel transcriptional regulatory element which was isolated from the MnSOD gene and which exhibits promoter-enhancer activity is disclosed. The promoter-enhancer activity of the element is further modulated by inflammatory mediators to regulate transcription. Methods of using the promoter-enhancer element to regulate gene expression, and therapeutic uses involving the promoter-enhancer element are also described.Type: GrantFiled: August 28, 2001Date of Patent: October 5, 2004Assignee: University of FloridaInventors: Harry S. Nick, Richard Rogers, John F. Valentine
-
Patent number: 6753171Abstract: A technique for controlling membrane denaturation reactions other than physical shear force was developed. For example, the present invention provides, a method for causing membrane disruption at a specific site by reacting a stimulus such as light with a compound that is activated by the stimulus, where the reaction occurs on a membrane such as a biomembrane. It also provides a membrane structure such as cells in which a specific site has been disrupted, which are obtained by the present method. Introduction of substances such as genes also became possible by using this membrane structure. Further provided is a membrane-destroying member for disrupting a membrane at a specific site. Thus, the present invention enabled, for example, easy membrane penetration using components constituting microelectrodes, micromanipulators, and microinjectors, which were conventionally hardly usable in penetrating cell membranes.Type: GrantFiled: December 28, 2000Date of Patent: June 22, 2004Assignee: Center for Advanced Science and Technology Incubation, Ltd.Inventors: Isao Karube, Takashi Saitoh
-
Patent number: 6677118Abstract: A process for the determination of CTp11 and for determining whether a tumor sample has metastatic potential is provided.Type: GrantFiled: November 10, 2000Date of Patent: January 13, 2004Assignee: Hoffman-La Roche Inc.Inventors: Goos van Muijen, Albert Zendman